167 related articles for article (PubMed ID: 34632855)
1. Combining contrast-enhanced ultrasound and blood cell analysis to improve diagnostic accuracy of plasma cell mastitis.
Zheng Y; Wang L; Han X; Shen L; Ling C; Qian Z; Zhu L; Dong F; Han Q
Exp Biol Med (Maywood); 2022 Jan; 247(2):97-105. PubMed ID: 34632855
[TBL] [Abstract][Full Text] [Related]
2. The discriminatory diagnostic value of multimodal ultrasound combined with blood cell analysis for granulomatous lobular mastitis and invasive ductal carcinoma of the breast.
Zeng YH; Yang YP; Liu LJ; Xie J; Dai HX; Zhou HL; Huang X; Huang RL; Liu EQ; Deng YJ; Li HJ; Wu JJ; Zhang GL; Liao ML; Xu XH
Clin Hemorheol Microcirc; 2024; 86(4):481-493. PubMed ID: 38007642
[TBL] [Abstract][Full Text] [Related]
3. Ultrasonic multimodality imaging features and the classification value of nonpuerperal mastitis.
Li C; Yao M; Li X; Shao S; Chen J; Li G; Jia C; Wu R
J Clin Ultrasound; 2022 Jun; 50(5):675-684. PubMed ID: 35475482
[TBL] [Abstract][Full Text] [Related]
4. Qualitative, quantitative and combination score systems in differential diagnosis of breast lesions by contrast-enhanced ultrasound.
Wang Y; Fan W; Zhao S; Zhang K; Zhang L; Zhang P; Ma R
Eur J Radiol; 2016 Jan; 85(1):48-54. PubMed ID: 26724648
[TBL] [Abstract][Full Text] [Related]
5. Clinical Value of Contrast-Enhanced Ultrasound in Breast Cancer Diagnosis.
Yuan Y; Xu M; Ren Y; He L; Chen J; Sun L
Comput Math Methods Med; 2022; 2022():2017026. PubMed ID: 36105240
[TBL] [Abstract][Full Text] [Related]
6. Combining ultrasonography and mammography to improve diagnostic accuracy of plasma cell mastitis.
Hu J; Huang X
J Xray Sci Technol; 2020; 28(3):555-561. PubMed ID: 32333573
[TBL] [Abstract][Full Text] [Related]
7. Application of contrast-enhanced ultrasound in the diagnosis of small breast lesions.
Du YR; Wu Y; Chen M; Gu XG
Clin Hemorheol Microcirc; 2018; 70(3):291-300. PubMed ID: 29710688
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of contrast-enhanced ultrasound for the differentiation of benign and malignant breast lesions.
Hu Q; Wang XY; Zhu SY; Kang LK; Xiao YJ; Zheng HY
Acta Radiol; 2015 Jan; 56(1):25-33. PubMed ID: 24436445
[TBL] [Abstract][Full Text] [Related]
9. Breast tumor size assessment: comparison of conventional ultrasound and contrast-enhanced ultrasound.
Jiang YX; Liu H; Liu JB; Zhu QL; Sun Q; Chang XY
Ultrasound Med Biol; 2007 Dec; 33(12):1873-81. PubMed ID: 17686569
[TBL] [Abstract][Full Text] [Related]
10. Adding contrast-enhanced ultrasound markers to conventional axillary ultrasound improves specificity for predicting axillary lymph node metastasis in patients with breast cancer.
Du LW; Liu HL; Gong HY; Ling LJ; Wang S; Li CY; Zong M
Br J Radiol; 2021 Feb; 94(1118):20200874. PubMed ID: 32976019
[TBL] [Abstract][Full Text] [Related]
11. A Prospective Study on the Value of Ultrasound Microflow Assessment to Distinguish Malignant from Benign Solid Breast Masses: Association between Ultrasound Parameters and Histologic Microvessel Densities.
Park AY; Kwon M; Woo OH; Cho KR; Park EK; Cha SH; Song SE; Lee JH; Cha J; Son GS; Seo BK
Korean J Radiol; 2019 May; 20(5):759-772. PubMed ID: 30993927
[TBL] [Abstract][Full Text] [Related]
12. Application of Contrast-Enhanced Ultrasound in the Diagnosis of Ductal Carcinoma In Situ: Analysis of 127 Cases.
Li W; Zhou Q; Xia S; Wu Y; Fei X; Wang Y; Tao L; Fan J; Zhou W
J Ultrasound Med; 2020 Jan; 39(1):39-50. PubMed ID: 31206200
[TBL] [Abstract][Full Text] [Related]
13. The clinical value of Arrival-time Parametric Imaging using contrast-enhanced ultrasonography in differentiating benign and malignant breast lesions.
Hu W; Dong Y; Zhang X; Zhang H; Li F; Bai M
Clin Hemorheol Microcirc; 2020; 75(3):369-382. PubMed ID: 32280085
[TBL] [Abstract][Full Text] [Related]
14. Papillary breast lesions on contrast-enhanced ultrasound: morphological enhancement patterns and diagnostic strategy.
Xia HS; Wang X; Ding H; Wen JX; Fan PL; Wang WP
Eur Radiol; 2014 Dec; 24(12):3178-90. PubMed ID: 25149297
[TBL] [Abstract][Full Text] [Related]
15. Meta-Analysis: Contrast-Enhanced Ultrasound Versus Conventional Ultrasound for Differentiation of Benign and Malignant Breast Lesions.
Li Q; Hu M; Chen Z; Li C; Zhang X; Song Y; Xiang F
Ultrasound Med Biol; 2018 May; 44(5):919-929. PubMed ID: 29530434
[TBL] [Abstract][Full Text] [Related]
16. The clinical role of contrast enhanced ultrasound in differential diagnosis of BI-RADS 4 breast disease.
Quan J; Hong Y; Zhang X; Mei M; You X; Huang P
Clin Hemorheol Microcirc; 2019; 72(3):293-303. PubMed ID: 30856103
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of sonazoid (perflubutane) for contrast-enhanced ultrasound in the differentiation of focal breast lesions: phase 3 multicenter clinical trial.
Miyamoto Y; Ito T; Takada E; Omoto K; Hirai T; Moriyasu F
AJR Am J Roentgenol; 2014 Apr; 202(4):W400-7. PubMed ID: 24660739
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of atypical hepatic hemangioma from liver metastases: Diagnostic performance of a novel type of color contrast enhanced ultrasound.
Wu XF; Bai XM; Yang W; Sun Y; Wang H; Wu W; Chen MH; Yan K
World J Gastroenterol; 2020 Mar; 26(9):960-972. PubMed ID: 32206006
[TBL] [Abstract][Full Text] [Related]
19. Differentiating benign from malignant solid breast lesions: combined utility of conventional ultrasound and contrast-enhanced ultrasound in comparison with magnetic resonance imaging.
Du J; Wang L; Wan CF; Hua J; Fang H; Chen J; Li FH
Eur J Radiol; 2012 Dec; 81(12):3890-9. PubMed ID: 23062280
[TBL] [Abstract][Full Text] [Related]
20. Incorporating Contrast-Enhanced Ultrasound into the BI-RADS Scoring System Improves Accuracy in Breast Tumor Diagnosis: A Preliminary Study in China.
Xiao X; Dong L; Jiang Q; Guan X; Wu H; Luo B
Ultrasound Med Biol; 2016 Nov; 42(11):2630-2638. PubMed ID: 27544439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
